Hamid Irannejad

About Hamid Irannejad

Hamid Irannejad, With an exceptional h-index of 18 and a recent h-index of 17 (since 2020), a distinguished researcher at Mazandaran University of Medical Sciences, specializes in the field of Medicinal Chemistry, Drug Design, Synthesis.

His recent articles reflect a diverse array of research interests and contributions to the field:

4‐{3‐[(Pyridin‐4‐ylmethyl)amino]‐[1,2,4]triazolo[4,3‐b][1,2,4]triazin‐6‐yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1 …

Affinity Prediction of Shikonins towards Sirtuins and the Requisite Structural Motifs for the Selective Inhibition of SIRT2 and SIRT3

Development of new PCR protocols to detect genetic diversity in the metronidazole metabolism genes in susceptible and refractory clinical samples of Giardia duodenalis

Engineering and design of promising T-cell-based multi-epitope vaccine candidates against leishmaniasis

Benzoindolizidine Alkaloids Tylophorine and Lycorine and Their Analogues with Antiviral, Anti-Inflammatory, and Anticancer Properties: Promises and Challenges

Polyethyleneglycol-serine nanoparticles as a novel antidote for organophosphate poisoning: synthesis, characterization, in vitro and in vivo studies

Anticancer Effect and Safety Profile of a 4-Pyridyl Linked Triazolotriazine Derivative against Colorectal Tumor

An Overview on Anti-COVID-19 Drug Achievements and Challenges Ahead

Hamid Irannejad Information

University

Position

Associate Professor of Medicinal Chemistry

Citations(all)

1118

Citations(since 2020)

728

Cited By

683

hIndex(all)

18

hIndex(since 2020)

17

i10Index(all)

29

i10Index(since 2020)

27

Email

University Profile Page

Google Scholar

Hamid Irannejad Skills & Research Interests

Medicinal Chemistry

Drug Design

Synthesis

Top articles of Hamid Irannejad

4‐{3‐[(Pyridin‐4‐ylmethyl)amino]‐[1,2,4]triazolo[4,3‐b][1,2,4]triazin‐6‐yl}phenol: An improved anticancer agent in hepatocellular carcinoma and a selective MDR1 …

Archiv der Pharmazie

2024/3/5

Hamid Irannejad
Hamid Irannejad

H-Index: 14

Affinity Prediction of Shikonins towards Sirtuins and the Requisite Structural Motifs for the Selective Inhibition of SIRT2 and SIRT3

Letters in Drug Design & Discovery

2024/3/1

Hamid Irannejad
Hamid Irannejad

H-Index: 14

Development of new PCR protocols to detect genetic diversity in the metronidazole metabolism genes in susceptible and refractory clinical samples of Giardia duodenalis

Acta Parasitologica

2024/3

Engineering and design of promising T-cell-based multi-epitope vaccine candidates against leishmaniasis

Scientific Reports

2023/11/8

Ali Khamesipour
Ali Khamesipour

H-Index: 38

Hamid Irannejad
Hamid Irannejad

H-Index: 14

Benzoindolizidine Alkaloids Tylophorine and Lycorine and Their Analogues with Antiviral, Anti-Inflammatory, and Anticancer Properties: Promises and Challenges

2023/9/24

Hamid Irannejad
Hamid Irannejad

H-Index: 14

Polyethyleneglycol-serine nanoparticles as a novel antidote for organophosphate poisoning: synthesis, characterization, in vitro and in vivo studies

Drug and Chemical Toxicology

2023/9/3

Anticancer Effect and Safety Profile of a 4-Pyridyl Linked Triazolotriazine Derivative against Colorectal Tumor

Journal of Sciences, Islamic Republic of Iran

2023/9/1

Seyed Jalal Hosseinimehr
Seyed Jalal Hosseinimehr

H-Index: 29

Hamid Irannejad
Hamid Irannejad

H-Index: 14

An Overview on Anti-COVID-19 Drug Achievements and Challenges Ahead

2023/8/16

Hamid Irannejad
Hamid Irannejad

H-Index: 14

Synthesis and evaluation of 99mTc-labeled 1-(2-Pyridyl) piperazine derivatives as radioligands for 5HT7 receptors

Bioorganic Chemistry

2023/6/1

Hamid Irannejad
Hamid Irannejad

H-Index: 14

Discovery of Chalcone-Based Hybrid Structures as High Affinity and Site-Specific Inhibitors against SARS-CoV-2: A Comprehensive Structural Analysis Based on Various Host-Based …

International Journal of Molecular Sciences

2023/5/15

Hamid Irannejad
Hamid Irannejad

H-Index: 14

Dual action anti‐inflammatory/antiviral isoquinoline alkaloids as potent naturally occurring anti‐SARS‐CoV‐2 agents: A combined pharmacological and medicinal chemistry perspective

2023/5

Hamid Irannejad
Hamid Irannejad

H-Index: 14

In silico design of a novel peptide-based vaccine against the ubiquitous apicomplexan Toxoplasma gondii using surface antigens

In silico pharmacology

2023/3/20

Hamid Irannejad
Hamid Irannejad

H-Index: 14

Application of emetine in SARS-CoV-2 treatment: Regulation of p38 MAPK signaling pathway for preventing emetine-induced cardiac complications

Cell Cycle

2022/11/17

Hamid Irannejad
Hamid Irannejad

H-Index: 14

Saeed Emami
Saeed Emami

H-Index: 6

Papaverine, a promising therapeutic agent for the treatment of COVID‐19 patients with underlying cardiovascular diseases (CVDs)

Drug Development Research

2022/9

Hamid Irannejad
Hamid Irannejad

H-Index: 14

Saeed Emami
Saeed Emami

H-Index: 6

Novel Molecular Targets and Mechanisms for Neuroprotective Modulation in Neurodegenerative Disorders

2022/8/1

Towards the First Multiepitope Vaccine Candidate against Neospora caninum in Mouse Model: Immunoinformatic Standpoint

BioMed Research international

2022/6/9

A Recent Update on the Clinical Trials and Effectiveness of Drugs Used in COVID-19, MERS and SARS Coronaviruses

Anti-Infective Agents

2022/6/1

Zohreh Karimi
Zohreh Karimi

H-Index: 4

Hamid Irannejad
Hamid Irannejad

H-Index: 14

Designing a novel multiepitope peptide vaccine against melanoma using immunoinformatics approach

Journal of Biomolecular Structure and Dynamics

2022/5/3

Engineering a multi-epitope vaccine candidate against Leishmania infantum using comprehensive Immunoinformatics methods

Biologia

2022/1

Therapeutic potential of chelerythrine as a multi-purpose adjuvant for the treatment of COVID-19

2021/11/17

Afshin Zarghi
Afshin Zarghi

H-Index: 28

Hamid Irannejad
Hamid Irannejad

H-Index: 14

See List of Professors in Hamid Irannejad University(Mazandaran University of Medical Sciences)